Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Lafayette › NPI 1598766495
Hospital

Our Lady of Lourdes Regional Medical Center, INC

Our Lady of Lourdes Regional Medical Center, INC was paid $54.20M by Medicaid between Jan 2018 and Dec 2024, across 257 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.

33Billing provider infoOUR LADY OF LOURDES REGIONAL MEDICAL CENTER, INC
LAFAYETTE, LA 70508
33aNPI1598766495assigned 08/02/2005
33bProvider typeCritical Access Hospital
28Total paid$54.20M
24GClaims1,319,876
24DCodes billed257
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Louisiana

Rank by total paid#1 of 40
Median peer was paid$3.19M
This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201859,986$1.58M
2019122,801$4.88M
2020135,422$5.36M
2021231,480$10.79M
2022271,852$12.15M
2023302,806$11.71M
2024incomplete195,529$7.74M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 74,688 67,819 $11.33M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 131,734 120,284 $10.93M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6.0% 35,563 31,423 $3.24M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 21,436 18,904 $2.85M
0202U Oncology (prostate), multianalyte, gene expression profiling 5.2% 9,596 8,490 $2.84M
16020 2.7% 6,069 3,586 $1.49M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.6% 41,922 33,929 $1.41M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 20,626 19,269 $1.07M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.9% 27,773 23,958 $1.02M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.7% 26,285 23,792 $946K
71046 Radiologic examination, chest; 2 views 1.7% 27,084 24,534 $906K
70450 Computed tomography, head or brain; without contrast material 1.6% 5,752 5,179 $893K
245 more codes
G0378 Hospital observation service, per hour 1.6% 6,639 $863K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.6% 29,619 $851K
96375 Therapeutic injection; each additional sequential IV push 1.4% 26,446 $774K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.4% 1,575 $773K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1.4% 2,012 $746K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 2,164 $621K
80053 Comprehensive metabolic panel 1.1% 88,227 $613K
99214 Doctor's office visit, returning patient (more involved) 1.1% 11,623 $587K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 27,491 $521K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 40,418 $506K
95811 <1% 1,080 $474K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 84,619 $426K
11043 <1% 1,873 $367K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,301 $357K
99213 Doctor's office visit, returning patient (routine) <1% 11,110 $357K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,439 $357K
87631 <1% 2,426 $316K
71045 Radiologic examination, chest; single view <1% 17,653 $308K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 799 $294K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,819 $243K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,860 $238K
95812 <1% 1,793 $232K
96361 Intravenous infusion, hydration; each additional hour <1% 13,729 $230K
36415 Collection of venous blood by venipuncture <1% 108,445 $206K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 1,055 $204K
37238 <1% 25 $187K
81025 <1% 27,369 $179K
87086 Culture, bacterial; quantitative colony count, urine <1% 27,328 $165K
81001 <1% 68,241 $143K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 10,148 $131K
86141 <1% 12,348 $127K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,638 $126K
84484 <1% 20,265 $122K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 415 $120K
99215 Doctor's office visit, returning patient (complex) <1% 2,324 $116K
74019 <1% 2,793 $99K
96376 <1% 2,719 $92K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 378 $83K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,666 $82K
94060 <1% 930 $81K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 610 $80K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,973 $80K
76819 Fetal biophysical profile; without non-stress testing <1% 758 $71K
85027 <1% 12,476 $68K
84702 <1% 5,334 $68K
76770 <1% 619 $62K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,344 $58K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,190 $49K
41899 Unlisted procedure, dentoalveolar structures <1% 120 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,127 $41K
93458 <1% 41 $36K
80048 Basic metabolic panel (calcium, ionized) <1% 6,370 $36K
82553 <1% 6,381 $35K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 16,017 $35K
87486 <1% 1,128 $34K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,209 $33K
87581 <1% 1,111 $33K
87428 <1% 1,107 $33K
C1760 Closure device, vascular (implantable/insertable) <1% 370 $33K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,050 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,048 $30K
87040 <1% 3,709 $29K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 373 $28K
C1769 Guide wire <1% 890 $27K
94729 <1% 510 $27K
83690 <1% 5,792 $27K
74018 <1% 1,069 $27K
86780 <1% 2,042 $26K
37252 <1% 32 $25K
C1876 Stent, non-coated/non-covered, with delivery system <1% 44 $24K
82550 <1% 7,305 $24K
72125 Computed tomography, cervical spine; without contrast material <1% 131 $23K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,018 $23K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 98 $21K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 18,971 $21K
95012 <1% 353 $20K
87088 <1% 2,522 $19K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 479 $19K
94726 <1% 442 $19K
73100 <1% 630 $17K
83036 Hemoglobin; glycosylated (A1C) <1% 1,831 $17K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 882 $16K
84145 <1% 772 $16K
76801 <1% 351 $15K
95816 <1% 130 $15K
C1753 Catheter, intravascular ultrasound <1% 51 $14K
94010 <1% 313 $14K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,960 $13K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 236 $13K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 148 $13K
73080 <1% 410 $13K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,764 $13K
86762 <1% 907 $13K
83880 <1% 679 $12K
70551 Magnetic resonance imaging, brain; without contrast material <1% 28 $10K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 30 $10K
87340 <1% 948 $9K
81003 <1% 5,292 $9K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 946 $9K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 139 $9K
86850 <1% 1,465 $8K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 129 $8K
29075 <1% 98 $8K
87070 <1% 1,249 $8K
93225 <1% 189 $8K
82962 <1% 3,082 $8K
42830 <1% 14 $7K
87807 <1% 682 $7K
84443 Thyroid stimulating hormone (TSH) <1% 458 $7K
82677 <1% 308 $7K
74021 <1% 165 $6K
77067 Screening mammography, bilateral, including computer-aided detection <1% 92 $6K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 76 $6K
86803 <1% 423 $6K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 152 $5K
82784 <1% 189 $5K
86900 <1% 1,858 $5K
86901 <1% 1,855 $5K
71275 Computed tomographic angiography, chest, with contrast material <1% 15 $5K
73130 <1% 111 $5K
86336 <1% 308 $5K
82105 <1% 308 $5K
82077 <1% 464 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 104 $4K
72082 <1% 109 $4K
84144 <1% 250 $4K
82728 <1% 275 $4K
86738 <1% 354 $4K
P9016 Red blood cells, leukocytes reduced, each unit <1% 14 $4K
75710 <1% 44 $4K
J3480 Injection, potassium chloride, per 2 meq <1% 520 $4K
86140 <1% 849 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 356 $3K
82950 <1% 694 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,174 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,878 $3K
85610 <1% 1,578 $3K
84439 <1% 353 $3K
85730 <1% 1,070 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 27,449 $3K
82785 <1% 156 $3K
72100 <1% 85 $3K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 288 $2K
73610 <1% 70 $2K
85007 <1% 958 $2K
94762 <1% 186 $2K
82787 <1% 170 $2K
72170 <1% 70 $2K
J2704 Injection, propofol, 10 mg <1% 1,813 $2K
72081 <1% 105 $2K
93226 <1% 32 $2K
87077 <1% 257 $2K
87186 <1% 265 $2K
83020 <1% 138 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 42 $2K
83615 <1% 350 $2K
16000 <1% 47 $2K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 500 $2K
85046 <1% 254 $1K
77072 <1% 27 $1K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 28 $1K
83540 <1% 227 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 13 $1K
36902 <1% 21 $1K
83735 <1% 361 $1K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 860 $1K
84550 <1% 343 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 2,564 $1K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 62 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 96 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,269 $1K
97597 <1% 43 $1K
82150 <1% 208 $1K
97602 <1% 36 $982.69
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 154 $974.98
76536 <1% 12 $960.96
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,510 $953.48
84703 <1% 147 $881.17
84480 <1% 119 $823.32
84436 <1% 154 $770.94
J1170 Injection, hydromorphone, up to 4 mg <1% 409 $767.74
95957 <1% 29 $729.72
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 94 $689.33
J7510 Prednisolone oral, per 5 mg <1% 169 $586.34
96367 <1% 13 $582.40
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 394 $543.38
77073 <1% 13 $536.16
73000 <1% 12 $521.04
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 546 $517.99
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 996 $499.10
87210 <1% 204 $473.28
J7050 Infusion, normal saline solution, 250 cc <1% 64 $469.46
73630 <1% 14 $466.18
73090 <1% 13 $450.45
82043 <1% 75 $424.38
75822 <1% 15 $402.88
82248 <1% 112 $392.83
J3360 Injection, diazepam, up to 5 mg <1% 25 $385.69
82570 <1% 75 $380.12
87081 <1% 52 $351.15
83605 <1% 63 $347.10
J0780 Injection, prochlorperazine, up to 10 mg <1% 49 $307.06
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 330 $294.85
83021 <1% 20 $278.90
82247 <1% 76 $273.78
C1755 Catheter, intraspinal <1% 30 $267.49
80143 <1% 25 $265.62
81511 <1% 221 $254.30
87427 <1% 12 $226.44
76937 <1% 166 $157.07
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,717 $153.11
87425 <1% 12 $146.52
85652 <1% 65 $144.30
80179 <1% 14 $134.25
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 30 $115.74
87045 <1% 12 $115.39
77063 Screening digital breast tomosynthesis, bilateral <1% 12 $105.48
94760 <1% 59 $80.48
98960 <1% 277 $80.10
85379 <1% 12 $71.26
84100 <1% 27 $71.10
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 91 $69.61
J1040 Injection, methylprednisolone acetate, 80 mg <1% 12 $69.37
J1010 Injection, methylprednisolone acetate, 1 mg <1% 16 $68.58
J2060 Injection, lorazepam, 2 mg <1% 26 $59.34
84156 <1% 13 $52.91
C1893 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away <1% 17 $47.26
85045 <1% 12 $45.17
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 238 $30.66
87205 <1% 22 $28.50
J2550 Injection, promethazine hcl, up to 50 mg <1% 25 $25.44
A9270 Non-covered item or service <1% 86 $22.49
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 69 $20.44
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 12 $14.95
30140 0% 335 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 20 $0.00
97010 0% 150 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 20 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 1,024 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 1,170 $0.00
J0290 Injection, ampicillin sodium, 500 mg 0% 120 $0.00
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units 0% 50 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 14 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 28 $0.00
02414 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMANSON, STEPHANIE (CEO)